Preclinical development of the PI3K Alpha selective and PIK3CA Mutant selective inhibitor GDC-0077 and prediction of its human pharmacokinetics. Issue 1 (January 2019) - Pang, Jodie; Baumgardner, Matthew; Braun, Marie-Gabrielle; Cheong, Jonathan; Edgar, Kyle; Friedman, Lori; Hanan, Emily; Jaochico, Allan; Ma, Shuguang; Plise, Emile; Schmidt, Stephen; Liu, Ning; et al.